drugset / Trial / NCT06509334
Trial of JYB1904 in Chronic Spontaneous Urticaria.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase II Trial is Meant to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Patients With Chronic Spontaneous Urticaria.
Timeline
- Start
- 2024-08-04
- Primary completion
- 2026-07-15
- Completion
- 2026-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OZUREPRUBART | Monoclonal antibody | — | — |
| Comparator | Omalizumab | Monoclonal antibody | — | — |